Global Foot and Ankle Allograft Market is expected to reach USD 391.71 million by 2024 from USD 273.37 million in 2016, at a CAGR of 4.7%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Browse Full Report: http://databridgemarketresearch.com/reports/global-foot-ankle-allograft-market/
The global foot and ankle allograft market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. The global foot and ankle allograft market is dominated CONMED Corporation, followed by Wright Medical Group N.V. and RTI Surgical, Inc. Other players in this market includeAmniox Medical, Inc., Zimmer Biomet, Arthrex, Inc., JRF Ortho, MTF Biologics, Integra Life Sciences Corporation, and Lattice Biologics Ltd., among others holds 38.0% of the global foot and ankle allograft market in 2016.
Founded in 1970 and headquartered at Utica, New York, U.S. CONMED Corporation is engaged in the development and marketing of surgical and patient monitoring products and services. The company operates through three business segments, namely, Orthopedic Surgery, General Surgery, and Surgical Visualization. The orthopedic segment offers a wide range of products for knee, shoulder, hip, foot and ankle, hand and wrist. General surgery segment includes wide range of laproscopic, robotic and open surgery products.
CONMED Corporation has 27 operating companies across the United States, Europe, and Asia-Pacific. Some of its subsidiaries include Aspen Laboratories, Inc. (Colorado), Andover Medical, Inc. (New York), Consolidated Medical Equipment Company (Mexico), EndoDynamix, Inc. (Delaware), GWH Limited Partnership (Florida), Linvatec Belgium NV (Belgium), Viking Systems, Inc. (Delaware).
WRIGHT MEDICAL GROUP N.V.:
Founded in 1940 and headquartered at Tennessee, U.S., Wright Medical, a global medical device company which focusses on designing, manufacturing, marketing, and selling extremities and biologics surgical. The fastest growing segments in orthopaedics are upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets.
Wright Medical Group N.V., has its presence in the United States, Europe, the Middle East, Africa. The company marketing and sells its products through direct sales representatives and independent sales agencies in the United States. Company’s has its direct sales offices and distributors in approximately 50 countries. Its subsidiaries are as follows BioMimetic Therapeutics, Inc. (U.S.), Wright Medical S.A (Europe), Tornier, Inc. (U.S.), WG Healthcare Limited (U.K.), Orthovert, Inc. (U.S.), TornierOrthopedics Ltd. (Ireland), DARCO International, Inc. (U.S.) and many more.
RTI Surgical, Inc:
Founded in 1997 and headquartered at Florida, U.S., RTI Surgical is a global surgical implant organization which provides surgeons and patients with an expanded portfolio of biologic, metal and synthetic implants for the treatment of spinal and other orthopedic disorders. It manufactures, develops, designs and distributes orthopedic and other surgical implants for the use in various surgical procedures worldwide. In order to produce xenograft and allograft implants along with the usage of BIOCLEANSE, CANCELLE SP and TUTOPLAST sterilization processes by donating human musculoskeletal and other tissues such as bones, tendons, cartilage, ligaments, pericardium, fascia lata, and dermal tissues.
RTI has additional U.S. locations in Marquette, Mich., Greenville, N.C., Austin, Texas and Jacksonville, Fla. with an international presence in Houten, The Netherlands, Neunkirchen, Germany and Singapore.
Global Foot and Ankle Allograft Market – Industry Trends and Forecast to 2026
Europe Foot And Ankle Allograft Market – Industry Trends and Forecast to 2024
North America Foot And Ankle Allograft Market – Industry Trends and Forecast to 2024
Asia-Pacific Foot And Ankle Allograft Market – Industry Trends and Forecast to 2024